Teveten

Teveten is a brand name of eprosartan, approved by the FDA in the following formulation(s):

TEVETEN (eprosartan mesylate - tablet; oral)

• 
  Manufacturer: ABBOTT
  
  Approval date: December 22, 1997
  
  Strength(s): EQ 400MG BASE ^[AB]


• 
  Manufacturer: ABBOTT
  
  Approval date: May 27, 1999
  
  Strength(s): EQ 600MG BASE ^[RLD][AB]

Has a generic version of Teveten been approved?

A generic version of Teveten has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Teveten and have been approved by the FDA:

eprosartan mesylate tablet; oral

• 
  Manufacturer: MYLAN PHARMS INC
  
  Approval date: November 16, 2011
  
  Strength(s): EQ 400MG BASE ^[AB], EQ 600MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Teveten. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Angiotensin II receptor blocking compositions
  Patent 5,656,650
  Issued: August 12, 1997
  Inventor(s): Weinstock; Joseph
  Assignee(s): SmithKline Beecham Corp.
  This invention relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier, an angiotensin II receptor antagonist and a second agent selected from a diuretic, a calcium channel blocker, a .beta.-adrenoceptor blocker, a renin inhibitor, or an angiotensin converting enzyme inhibitor and a method of treating hypertension.
  
  Patent expiration dates:
  
  
  • August 12, 2014
    
    ✓ 
    Patent use: TREATMENT OF HYPERTENSION
  
  

See also...

• Teveten Consumer Information (Wolters Kluwer)
• Teveten Consumer Information (Cerner Multum)
• Teveten Advanced Consumer Information (Micromedex)
• Teveten AHFS DI Monographs (ASHP)
• Eprosartan Consumer Information (Wolters Kluwer)
• Eprosartan Consumer Information (Cerner Multum)
• Eprosartan Advanced Consumer Information (Micromedex)
• Eprosartan Mesylate AHFS DI Monographs (ASHP)